Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/1999
12/16/1999WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines
12/16/1999WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999DE19913921A1 Gassensorelement Gas sensor element
12/16/1999DE19825095A1 Verfahren zur Bestimmung des Gehalts vorbestimmter Inhaltsstoffe mit stochastischer Verteilung in Warengütern, die von fester und inhomogener Konsistenz sind Method for determining the content of predetermined ingredients with stochastic distribution of goods in goods that are of fixed and non-homogeneous consistency
12/16/1999DE19825079A1 Calibration fluid for a sensor to measure blood values
12/16/1999DE19824959A1 Chemo- or bio-sensor for determining specific analytes
12/16/1999DE19824629A1 Biosensor for in-situ study of reduction-oxidation processes
12/16/1999DE19824609A1 Method for monitoring contents fluid and gaseous and paste type fluids and for online exchange of data with data station
12/16/1999CA2410694A1 Porcine reproductive and respiratory syndrome virus (prrsv) dna vaccines
12/16/1999CA2335007A1 Retinoic acid inducible dna sequences from lung cells
12/16/1999CA2334966A1 Screening method for dehydrogenase oligomerisation modulators
12/16/1999CA2334892A1 Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same
12/16/1999CA2334759A1 Automatic analysis apparatus used for timing blood coagulation
12/16/1999CA2334712A1 Detection of ligands with signal amplification
12/16/1999CA2334709A1 Method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition
12/16/1999CA2334215A1 Transformed cell lines which express heterologous g-protein-coupled receptors
12/16/1999CA2333890A1 Inhibition of coagulation in blood and blood products
12/16/1999CA2333331A1 Stabilized transient gene expression
12/16/1999CA2332993A1 Phagocytic assay method
12/16/1999CA2332349A1 Predictive test for pre-eclampsia
12/16/1999CA2331825A1 Methods and kits for discovery of rna-binding compounds
12/16/1999CA2331372A1 Tankyrase, a trfi binding protein
12/16/1999CA2330246A1 A method of identifying ligands to rna polymerase sigma 70 subunit
12/16/1999CA2330238A1 Vaccine
12/16/1999CA2330230A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt)
12/16/1999CA2330229A1 Novel angiotensin receptor, production and use thereof
12/16/1999CA2329948A1 Solution-phase elisa
12/16/1999CA2329942A1 Therapeutic and diagnostic domain 1 .beta.2gpi polypeptides and methods of using same
12/16/1999CA2328498A1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same____________________________________
12/16/1999CA2321274A1 Novel antiviral compounds
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321191A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
12/16/1999CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999CA2321162A1 Novel antibacterial compounds
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2320290A1 Multibinding inhibitors of cyclooxygenase-2
12/16/1999CA2320241A1 Multivalent macrolide antibiotics
12/16/1999CA2319761A1 Multibinding inhibitors of hmg-coa reductase
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319174A1 Novel therapeutic agents that modulate 5-ht receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319153A1 Novel sodium channel drugs and uses
12/16/1999CA2319142A1 Novel therapeutic agents for membrane transporters
12/16/1999CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318901A1 Novel calcium channel drugs and uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318806A1 Multibinding agents that modulate the 5-ht transporter
12/16/1999CA2318745A1 Novel potassium channel drugs and their uses
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2316999A1 Inhibitors of hiv reverse transcriptase
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/16/1999CA2313047A1 Multiple assay method
12/16/1999CA2240779A1 Porcine reproductive and respiratory syndrome virus (prrsv) dna vaccines
12/15/1999EP0964250A1 Diagnostic drugs for autoimmune diseases
12/15/1999EP0964249A2 Method for measuring LDL-cholesterol
12/15/1999EP0964245A2 Electrochemical analysis element
12/15/1999EP0964060A2 Method for quantitating a substrate and measurement device used therefor
12/15/1999EP0963980A2 1,2,4-Triazine derivative, its preparation and its use as reference marker for testing purity and stability of "lamotrigine"
12/15/1999EP0963555A1 Means for determining the degree of acidity of the urine of a cat
12/15/1999EP0963554A1 Method for the immunological determination of an analyte
12/15/1999EP0963553A1 Solid phase immunoassay
12/15/1999EP0963552A1 System for detecting amine and other basic molecular contamination in a gas
12/15/1999EP0963550A1 Ion-selective electrode and method for selective determination of analytes in body fluids
12/15/1999EP0963443A1 Releasable nonvolatile mass-label molecules
12/15/1999EP0963438A1 RECOMBINANT P37/FlaA AS A DIAGNOSTIC REAGENT
12/15/1999EP0963436A1 Nucleic acid encoding congenital heart disease protein and products related thereto
12/15/1999EP0963432A1 Kuz, a novel family of metalloproteases
12/15/1999EP0963431A1 NOVEL FabH
12/15/1999EP0963376A1 Prokaryotic two-hybrid system
12/15/1999EP0963205A1 T1 receptor-like ligand ii
12/15/1999EP0963192A2 Diaminobenzoic acid derivatives as dye precursors
12/15/1999EP0785910B1 Apparatus and process for fluid treatment
12/15/1999EP0772616B1 Hydrophilic metal complexes
12/15/1999EP0750612B1 Acridone-derived bisintercalators as chemotherapeutic agents
12/15/1999EP0623167B1 Preparation of mystery disease virus antigens and vaccines and antigens and vaccines produced for the prevention of this disease
12/15/1999EP0567567B1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
12/15/1999CN2354141Y Multifunction integrated microcavity-array biological sensor
12/15/1999CN2354140Y Plasma ion-energy measuring and analyzing instrument
12/15/1999CN2354139Y Pocket physical-quantity measuring instrument
12/15/1999CN1238807A Stabilized transient gene expression
12/15/1999CN1238783A Method and novel compounds for use therein
12/15/1999CN1238778A Method for determining expression of aberrant forms of APC protein
12/15/1999CN1238456A PCR method for testing nucleic acid by fluoremtetry and its reagent box